BioNTech SE Chief Commercial Officer Annemarie Hanekamp files initial beneficial ownership statement

Reuters03-19
<a href="https://laohu8.com/S/BNTX">BioNTech SE</a> Chief Commercial Officer Annemarie Hanekamp files initial beneficial ownership statement

BioNTech reported that Annemarie Hanekamp filed an initial statement of beneficial ownership as Chief Commercial Officer. The filing listed 8,838 ordinary shares underlying an option. It also reported 11,047 ordinary shares underlying performance share units.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-114382), on March 18, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment